KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Goodwill (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Goodwill data on record, last reported at $597.4 million in Q2 2025.

  • For Q2 2025, Goodwill changed N/A year-over-year to $597.4 million; the TTM value through Jun 2025 reached $597.4 million, changed N/A, while the annual FY2024 figure was $597.4 million, 0.2% changed from the prior year.
  • Goodwill reached $597.4 million in Q2 2025 per AMRX's latest filing, roughly flat from $597.5 million in the prior quarter.
  • Across five years, Goodwill topped out at $598.9 million in Q4 2022 and bottomed at $593.0 million in Q4 2021.
  • Average Goodwill over 5 years is $597.4 million, with a median of $597.5 million recorded in 2025.
  • Peak YoY movement for Goodwill: rose 13.43% in 2021, then decreased 0.2% in 2024.
  • A 5-year view of Goodwill shows it stood at $593.0 million in 2021, then rose by 0.98% to $598.9 million in 2022, then fell by 0.04% to $598.6 million in 2023, then decreased by 0.2% to $597.4 million in 2024, then fell by 0.01% to $597.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $597.4 million in Q2 2025, $597.5 million in Q1 2025, and $597.4 million in Q4 2024.